10000 documents

Identification of neutralizing epitopes on SARS-CoV-2 spike for design of vaccines and small-molecule antivirals

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

Dennis R. Burton · SCRIPPS RESEARCH INSTITUTE, THE · 2021 · $635,619 — Coronaviruses (CoVs) are enveloped, positive-sense, single-stranded RNA viruses and are divided into Alphaand Beta-coronaviruses. CoVs infect mammals and birds and typically result in lower and/or upper respiratory tract disease. The spectrum of illness in humans caused by CoVs range from common co…

Development of a novel adjuvant strategy enabled by modulation of the physical properties of fungal mannans

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

Ivan Zanoni · BOSTON CHILDREN'S HOSPITAL · 2021 · $777,874 — PROJECT SUMMARY Vaccines represent a highly effective public health measure to protect individuals from infectious diseases. Many vaccines work by inducing antigen-specific antibodies that neutralize the pathogen or its products and promote their clearance. Vaccines based on protein antigens usually…

COVID19: SARS-CoV-2 and ACE2 interaction in hypertension

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

Eric D Lazartigues · SOUTHEAST LOUISIANA VETERANS HEALTH CARE · 2021 — The current COVID-19 pandemic is one of the most disruptive events in human history, caused by the SARS- CoV-2 virus, member of the coronavirus family that uses angiotensin converting enzyme 2 (ACE2), a transmembrane carboxypeptidase identified as a member of the renin-angiotensin system (RAS) as an…

Large scale in vitro production of capped polyadenylated mRNA-based vaccines in solid phase using immobilized enzymes

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

Maria Kireeva · AFFINITY MOLECULES, LLC · 2021 · $297,193 — ABSTRACT RNA emerges as a promising therapeutic agent and is becoming an increasingly popular tool for delivery of genetic information to cultured cells and living organisms. Notably, mRNA is used as a basis for new vaccine development and personalized gene therapy and is replacing DNA vectors in a …

CaMKII biophysics and its role in LTP

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

Margaret M Stratton · UNIVERSITY OF MASSACHUSETTS AMHERST · 2021 · $313,229 — PROJECT SUMMARY How does a memory outlast the lifetime of the molecule that encodes it? More than two decades ago, Francis Crick had the foresight to speculate that perhaps a multimeric protein could serve as a molecular memory by sharing its activation state with newly synthesized proteins through …

Molecular Mechanisms of Viral Entry by Membrane Fusion

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

LUKAS K TAMM · UNIVERSITY OF VIRGINIA · 2021 · $562,219 — PROJECT SUMMARY Membrane fusion, mediated by viral spike glycoproteins, is a key process in the infection cycle of all enveloped human and animal viruses. The overall goal of this project is to understand the molecular mechanisms of Ebola and human immunodeficiency virus entry by membrane fusion, by…

Structure of HIV-1 envelope spike in the context of membrane

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

Bing Chen · BOSTON CHILDREN'S HOSPITAL · 2021 · $531,000 — Project Summary Membrane fusion, mediated by HIV-1 envelope glycoprotein [Env; trimeric (gp160)3 cleaved to (gp120/gp41)3], is the first critical step for the virus to enter host cells and establish infection. A mature Env spike contains three copies each of noncovalently-associated receptor-binding…

Thermostabilized Subunit Glycoprotein Vaccine Platform: Immune Characterization of an Emulsified Adjuvant with SARS-CoV-2 Spike Protein and EBOV GP

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

Oreola Donini · SOLIGENIX, INC. · 2021 · $636,664 — 7. Project Summary/Abstract The proposal requests funding to support manufacturing and immune characterization of a novel, emulsified adjuvant which is uniquely compatible with lyophilization strategies to enable thermostabilization of glycoprotein vaccines. The major objectives of the study are to …

A muco-penetrating biomaterial-based subunit vaccine for programming protective immune responses to SARS-CoV-2

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

David Scott Wilson · JOHNS HOPKINS UNIVERSITY · 2021 · $204,688 — 1. ABSTRACT/SUMMARY Given that the site of entry of SARS-CoV-2 is the respiratory mucosa, an effective vaccine for SARS-CoV-2 should initiate both humoral and respiratory mucosal immune responses. Although an intranasal subunit vaccine would be an ideal platform for SARS-CoV-2, transport across the …

Defining clinically relevant viral epitopes with cow antibodies

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

Vaughn Vasil Smider · APPLIED BIOMEDICAL SCIENCE INSTITUTE · 2021 · $352,893 — Vaccines are the primary means by which to prevent, control, or eradicate infectious diseases. While many vaccines have been successfully developed and have resulted in enormous medical and veterinary benefit, there are certain viruses that have eluded effective vaccine development. Generally, virus…

Molecular Mechanism of Hippocampal network excitability in a novel, in vivo model of Tuberous Sclerosis Complex

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

Kimberly Frances Raab-Graham · WAKE FOREST UNIVERSITY HEALTH SCIENCES · 2021 · $335,999 — PROJECT SUMMARY Overview: The project focuses on understanding the molecular basis of how disrupted calcium homeostasis leads to disrupted hippocampal network activity that results in maladaptive responses in neurons with TSC deficient signaling. Approximately 33% of children who have autism spectru…

Ultrasensitive HIV viral load quantitation using designer DNA nanostructure capture probes and photonic resonator interference scattering microscopy

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

Brian T. Cunningham · STANFORD UNIVERSITY · 2021 · $742,137 — Abstract Frequent, accurate, and highly sensitive HIV-1 viral load monitoring is a critical component of AIDS antiretroviral therapy, a tool for reducing the incidence of mother-to-child HIV transmission, and a required element of routine diagnostic testing to make people aware of their HIV status. …

PanCorVac (Center for Pan-Coronavirus Vaccine Development)

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

YOSHIHIRO KAWAOKA · UNIVERSITY OF WISCONSIN-MADISON · 2021 · $7,000,324 — SUMMARY Most of the vaccines currently approved or in development against the pandemic SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) virus target immunodominant, strain-specific epitopes in the SARS-CoV-2 spike (S) protein and are therefore not expected to confer protection against o…

Discovering Durable Pan-Coronavirus Immunity

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

Duane R. Wesemann · BRIGHAM AND WOMEN'S HOSPITAL · 2021 · $11,809,995 — OVERALL SUMMARY Severe Acute Respiratory Syndrome (SARS) Coronavirus (CoV)-2 is a devastating human threat. While successful vaccine programs are underway, genetic drift and immune escape have already begun to subvert immunity, with more variants likely to continue to emerge. Moreover, the rates of …

Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

KATHERINE D MCREYNOLDS · CALIFORNIA STATE UNIVERSITY SACRAMENTO · 2021 · $106,500 — PROJECT SUMMARY/ABSTRACT The current COVID-19 pandemic has resulted in millions of infections and over 2 million deaths worldwide since SARS-CoV-2 emerged in Wuhan, China in December of 2019. This pandemic has revealed a significant treatment gap in the ability to minimize the morbidity and mortali…

The Role of the Host Ubiquitin System in Promoting SARS-CoV-2 Replication and Pathogenesis

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

Ricardo Rajsbaum · UNIVERSITY OF TEXAS MED BR GALVESTON · 2021 · $256,790 — The Severe Acute Respiratory Syndrome Coronavirus 2 (CoV-2) belongs to a family of pathogenic enveloped RNA viruses of the family Coronaviridae. The ongoing pandemic has caused a public health emergency worldwide, accompanied by dire health and economic consequences. There is evidence suggesting tha…

The origin and future protective activity of SARS-CoV-2 RBD specific neutralizing antibodies

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

James J Kobie · UNIVERSITY OF ALABAMA AT BIRMINGHAM · 2021 · $856,430 — PROJECT SUMMARY SARS-CoV-2 has infected over 138 million people and resulted in over 2.8 million deaths so far, with the expectation the pandemic will continue for many more months, and the virus will persist endemically for years, exacerbated by emerging variants of concern (VoC). Although several …

Infection and Rapid Transmission of SARS-C0V-2 in Ferrets

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

Jae U Jung · CLEVELAND CLINIC LERNER COM-CWRU · 2021 · $532,961 — Project Summary/Abstract The massive outbreak of newly emerged coronavirus disease 2019 (COVID-19) has been rapidly spread worldwide, leading to a pandemic infection and serious global health emergency. In order to prevent further dissemination of severe acute respiratory syndrome coronavirus 2 (SA…

The Science of COVID-19 Vaccines

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

Tim M. Herman · MILWAUKEE SCHOOL OF ENGINEERING · 2021 · $53,568 — This request for supplemental funds will allow us to expand and refine instructional materials addressing the science of coronavirus and the role that vaccines can play in eradicating this virus. Instructional materials that will be created with these supplemental funds include (i) a video that spec…

Structure, Function and Antigenicity of Coronavirus Spike Proteins

NIH Pandemic-Era Grants · Pandemic Era Grants / 2021

Jason Scott McLellan · UNIVERSITY OF TEXAS AT AUSTIN · 2021 · $613,032 — Coronaviruses have the largest genomes among known RNA viruses and are phylogenetically divided into four genera. Some betacoronaviruses, such as HKU1, circulate annually in humans and cause mild yet prevalent respiratory disease whereas others, such as SARS-CoV and the recently emerged MERS-CoV, ha…